The experiment in vivo with tumor PDX model showed that purified RANK-N could inhibit tumor growth in vivo; however, the role and underlying mechanism of the RANKL/RANK pathway in cancer need to be further investigated. This evidence concerns the gene TNFSF11 and cancer.